showed that lncRNA AGAP2-AS1 recruited EZH2 and LSD1 to the promoter regions of KLF2 and large tumor suppressor 2 (LATS2), thus, inhibiting the transcription of KLF2 as well as LATS2 and promoting the non-small cell lung cancer progression (55). The gene discussed is LATS2; the disease is non-small cell lung carcinoma.